Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Why is PPS rising???
I pay cash, Ive reduced my pills to twice daily do to cost, I use their coupon, I pay $84 for 60
How about the radical right !!!! He controls it by the shit he spews out of his mouth!!!
This is not a political platform...
I got it too,, Using he coupon to pay cash.... on Medicare..
4 blocks sold at .60 over 238K wow
Why so much selling...Dilution ???
Lol.
I wish that our management was as great as Rlftf.. They are quite transparent and seem to be ready to commence with their plans upon EUA approval. They have built a great foundation from whence to begin. Hard to imagine that several months ago this drug was only on paper..
Yes I am familiar with him and its success, but at app $70, i am kinda tapped out from my losses of this piece of shit at this point. I will look into it though.. Thanks as always. Hopefully EUA comes thru soon..
I'm familiar with it, what are you expecting in PPS
SWAV to expensive for me...Relief is just right....
Where is the paper work...LOL
I guess....
About 80% of Asymptomatic People With
COVID-19 Develop Symptoms
Approximately 20% of asymptomatic people who test positive for COVID-19 will remain symptom-free over time, according to two studies published September 22 in different journals. The researchers propose, therefore, that most asymptomatic patients should be considered presymptomatic.
"Only a minority of people with SARS-CoV-2 have a truly asymptomatic infection. Most patients with SARS-CoV-2 who are asymptomatic at the time of testing will go on to develop symptoms," study author Nicola Low, MD, head of the Research Group at the Institute of Social and Preventive Medicine at the University of Bern in Switzerland, told Medscape Medical News.
The result also suggests expanded testing for SARS-CoV-2 infection is warranted, especially among those at higher risk, and supports use of control measures including masks, physical distancing, and isolation.
"People with asymptomatic infection are infectious. All should be isolated and contact tracing should be started," Low added.
Low and colleagues performed a living systemic review and meta-analysis evaluating the occurrence and transmission of asymptomatic and presymptomatic patients. They published their findings in PLOS Medicine.
Sung-Han Kim, MD, PhD, and co-investigators conducted a study comparing levels of SARS-CoV-2 in the nose and throat of asymptomatic vs symptomatic individuals published in the journal Thorax.
The research teams out of Switzerland and South Korea point to a need for more clarity on which patients with COVID-19 are asymptomatic vs presymptomatic. Most previous researchers tested people for SARS-CoV-2 infection at a single time, preventing identification of the percentage who subsequently developed symptoms.
About 80% of Asymptomatic People With
COVID-19 Develop Symptoms
Approximately 20% of asymptomatic people who test positive for COVID-19 will remain symptom-free over time, according to two studies published September 22 in different journals. The researchers propose, therefore, that most asymptomatic patients should be considered presymptomatic.
"Only a minority of people with SARS-CoV-2 have a truly asymptomatic infection. Most patients with SARS-CoV-2 who are asymptomatic at the time of testing will go on to develop symptoms," study author Nicola Low, MD, head of the Research Group at the Institute of Social and Preventive Medicine at the University of Bern in Switzerland, told Medscape Medical News.
The result also suggests expanded testing for SARS-CoV-2 infection is warranted, especially among those at higher risk, and supports use of control measures including masks, physical distancing, and isolation.
"People with asymptomatic infection are infectious. All should be isolated and contact tracing should be started," Low added.
Low and colleagues performed a living systemic review and meta-analysis evaluating the occurrence and transmission of asymptomatic and presymptomatic patients. They published their findings in PLOS Medicine.
Sung-Han Kim, MD, PhD, and co-investigators conducted a study comparing levels of SARS-CoV-2 in the nose and throat of asymptomatic vs symptomatic individuals published in the journal Thorax.
The research teams out of Switzerland and South Korea point to a need for more clarity on which patients with COVID-19 are asymptomatic vs presymptomatic. Most previous researchers tested people for SARS-CoV-2 infection at a single time, preventing identification of the percentage who subsequently developed symptoms.
How can we have a 2/1 buy/sell ratio and see a .01 Rise..Kinda criminal....
It's a mystery to me LOL
Its there, towards the bottom, I concur....
I'm in where is your info from or just speculation like all others...
to late its gone,,,lol
THE GAMES THEY PLAY SO SAD!!!!
Other than their options....What do they gain by this stupidity????
Where did you hear this?
Yea he lost money if he is a flipper lol
What hit, we wait any longer, this company will be worth pennies on the dollar unless BOD do something!!!!!
I ave. .30
Because its not gained traction as the cure yet, Its an OTC stock whereby large institutions can not participate in. When it is announced in The US Papers...Then we shall gain acceptance...IMO
A Must to Listen too. RLFTF
https://view.vzaar.com/22010741/player
Dr Javits at a Sachs Conference...
Bet that their options are still on the table!!!!!
Just love the way the MM's wont let the PPS go over .59, SO CRIMINAL...IMO
Its getting outta hand....
Its about the P Value
Here is .001 !!!
Why is there no short squeeze today...
Why not give it to them for free??
I agree it’s a top echelon peer review group. Positive review will drive the stock. Love the patent app for Samivir for a plethora of diseases both over and inhalation use. Let’s hope that mondays conference brings more good fortunes.
Have a great weekend
Preston
I agree it’s a top echelon peer review group. Positive review will drive the stock. Love the patent app for Samivir for a plethora of diseases both over and inhalation use. Let’s hope that mondays conference brings more good fortunes.
Have a great weekend
Preston
Unless they were to get fast track, it will take a long time!!!
Guess that the buy/sell ratio does not mean anything...LOL
only 3 million shares, not a lot yet
SIX Swiss Exchange 0.5593 9/17/2020 39.95 mill. +18.14% 0.7707 0.5505
Look at that ask/bid !!!!!